日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Upper-layer ozone intrusion promotes wintertime secondary aerosol formation on the ground

高空臭氧入侵促进冬季地面二次气溶胶的形成

Wang, Yuzheng; Liu, Yongchun; Zheng, Feixue; Ma, Wei; Zhang, Yusheng; Hua, Chenjie; Chen, Xin; Xie, Jiali; Wang, Zongcheng; Ma, Pengkun; Liao, Zhiheng; Xia, Men; Yuan, Qi; Du, Wei; Zhao, Xiaoxi; Hu, Bo; Quan, Jiannong; Bianchi, Federico; Kerminen, Veli-Matti; Petäjä, Tuukka; Bao, Xiaolei; Zhao, Shuli; Jiang, Jingkun; Ding, Aijun; Kulmala, Markku; Worsnop, Douglas R

Correction: DNAJC5 promotes cisplatin resistance in epithelial ovarian cancer by autophagy induced by the BiP/IRE1α/XBP1 endoplasmic reticulum stress pathway

更正:DNAJC5通过BiP/IRE1α/XBP1内质网应激通路诱导的自噬促进上皮性卵巢癌的顺铂耐药性。

Huang, Shijia; Chen, Ling; Chen, Yirong; Lu, Siyan; Yang, Bowen; Chen, Ya; Zhao, Wei; Zhao, Shuli

A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair

一种新型C1QBP肽抑制剂通过损害线粒体功能和抑制同源重组修复,对三阴性乳腺癌表现出强大的抗肿瘤活性。

Li, Xingxing; Wu, Yue; Zhang, Min; Wang, Fengliang; Yin, Hong; Zhang, Yanrong; Zhao, Shuli; Ma, Jiehua; Lv, Mingming; Lu, Cheng

Development of a (177)Lu-labeled EphA2-targeting cyclic peptide combined with an HPK1 inhibitor for synergistic anti-tumor effects

开发一种(177)Lu标记的靶向EphA2的环状肽,并将其与HPK1抑制剂联合使用,以产生协同抗肿瘤作用

Zhang, Meng-Jie; Chen, Yirong; Zhang, Caixia; Bian, Xiaofeng; Zhang, Xiangyang; Huang, Shijia; Yang, Bowen; Lu, Siyan; Fu, Xueting; Zhao, Wei; Kong, Xu-Dong; Zhao, Shuli

CD81 Aggravates Ovarian Cancer Progression via p-Cresyl Sulfate-Mediated Mitophagy in Tim4(+) Tumour-Associated Macrophages.

CD81 通过对甲酚硫酸酯介导的 Tim4(+) 肿瘤相关巨噬细胞线粒体自噬加剧卵巢癌的进展

Ni Jiali, Li Xiaoying, Wu Yue, Tu Xiaodi, Zhang Xinxin, Wang Lu, Xie Hao, Hou Yayi, Dou Huan, Zhao Shuli

NR4A3high mast cells promote ovarian cancer metastasis by reprogramming tumor-associated macrophages via JAK2/STAT6 signaling

NR4A3高表达的肥大细胞通过JAK2/STAT6信号通路重编程肿瘤相关巨噬细胞,从而促进卵巢癌转移。

Bian, Xiaofeng; Chen, Yirong; Zhang, Caixia; Huang, Shijia; Fu, Xueting; Yang, Bowen; Lu, Siyan; Zhao, Wei; Pan, Yan; Zhao, Shuli

DNAJC5 promotes cisplatin resistance in epithelial ovarian cancer by autophagy induced by the BiP/IRE1α/XBP1 endoplasmic reticulum stress pathway.

DNAJC5 通过 BiP/IRE1α/XBP1 内质网应激途径诱导的自噬促进上皮性卵巢癌的顺铂耐药性。

Huang Shijia, Chen Ling, Chen Yirong, Lu Siyan, Yang Bowen, Chen Ya, Zhao Wei, Zhao Shuli

Predicting immunotherapeutic response and therapeutic targets by stemness classification of acute myeloid leukemia by stemness score

通过干细胞评分对急性髓系白血病进行干细胞分类,预测免疫治疗反应和治疗靶点

Yang, Xin; Zhang, Yu; Deng, Shuzhen; Wang, Ying; Zhao, Shuli; Cheng, Yujing; Zhang, Chan

Cell sheet formation enhances the therapeutic effects of adipose-derived stromal vascular fraction on urethral stricture

细胞片层形成增强了脂肪来源基质血管成分对尿道狭窄的治疗效果

Li, Muxin; Yang, Tianli; Zhao, Jun; Ma, Xinghua; Cao, Yuanyuan; Hu, Xiaojie; Zhao, Shuli; Zhou, Liuhua

FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer

FSTL3通过稳定结直肠癌中的c-Myc,促进肿瘤免疫逃逸并减弱对PD-1抑制剂治疗的反应。

Li, Haiyang; Zheng, Na; Guo, Anning; Tang, Weiwei; Li, Muxin; Cao, Yuanyuan; Ma, Xinhua; Cao, Hongyong; Ma, Yong; Wang, Hanjin; Zhao, Shuli